What does the research say about oxidative stress?

Oxidative stress is the formal term for a state in which the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) exceeds the capacity of endogenous antioxidant defence systems to neutralise them. It is not a single molecule but a class of cellular conditions, and it has no sequence, formula or molecular weight of its own; the identifiers that appear in the literature belong to the individual markers used to estimate it, such as glutathione, malondialdehyde, and the selenoprotein glutathione peroxidase 4 (GPX4). Synonyms in common use include redox imbalance, oxidative burden, and antioxidant depletion.

The research summarised here centres on the redox and antioxidant-response pathways that cells use to buffer reactive species, including the glutathione and thioredoxin systems, the transcription factor NRF2 and its downstream antioxidant response element, and mitochondrial electron transport as a principal site of ROS generation.

Research Studies

Vitamin E and oxidative stress markers in levothyroxine-treated hypothyroidism

A registered trial is investigating whether vitamin E supplementation, given as an adjunct to levothyroxine therapy, reduces oxidative stress and improves antioxidant defence mechanisms in patients with hypothyroidism, and whether it favourably influences thyroid hormone status [1]. The stated aim is to establish an evidence-based framework for integrating targeted antioxidant therapies into standard hypothyroid management. No outcome data are reported in the registry record.

Zinc and insulin resistance in polyendocrine metabolic ovarian syndrome

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is described as the most common endocrinopathy in women of reproductive age, mechanistically anchored in insulin resistance and driving hyperandrogenism, anovulation, dyslipidaemia and long-term type 2 diabetes risk [2]. The trial focuses on South Asian women, including Bangladeshi women, who are reported to develop insulin resistance at lower BMI thresholds than other populations and to carry a high burden of zinc deficiency, with 57% of non-pregnant, non-lactating women affected [2]. Zinc is structurally required for pancreatic beta-cell insulin synthesis, modulates insulin-receptor signalling and PI3K/Akt-mediated glucose uptake, and acts as a cofactor for Cu/Zn-superoxide dismutase [2].

Nicotinamide riboside and walking distance in peripheral artery disease

The NICE-PAD II trial is testing whether participants with peripheral artery disease (PAD) aged 50 and older randomised to nicotinamide riboside show greater improvement or less decline in six-minute walk distance at six-month follow-up compared with placebo [3]. The study will randomise 250 participants to nicotinamide riboside or placebo for six months. The primary outcome is change in six-minute walk distance; secondary outcomes include Walking Impairment Questionnaire distance score, PROMIS Mobility score, and calf muscle perfusion measured by magnetic resonance arterial spin labelling [3].

N-acetylcysteine and repetitive behaviours in Cornelia de Lange syndrome

A randomised cross-over pilot trial is testing the efficacy of N-acetylcysteine (NAC) for repetitive behaviours and self-injurious behaviour in patients with Cornelia de Lange syndrome (CdLS) [4]. NAC is described in the record as a known anti-oxidative stress and neuroprotective agent that has been shown to decrease the occurrence of self-injurious behaviour such as skin picking, and that has shown partial response in trials for compulsive behaviours in obsessive-compulsive disorder and related disorders in autism [4]. CdLS is a genetic disorder with autistic features, including repetitive and self-injurious behaviours [4].

GPX4 expression after Kono-S versus conventional anastomosis in Crohn's disease

Crohn's disease is a long-term condition causing bowel inflammation, and many patients require surgery to remove damaged intestinal sections; disease often recurs near the anastomosis where the bowel is reconnected [5]. The Kono-S anastomosis is a newer technique designed to reduce recurrence risk, and early results are described as promising, though it is not fully understood why it may outperform traditional methods [5]. This project examines how the bowel heals after surgery by looking at oxidative stress and GPX4 expression [5].

Oral melatonin as adjunctive therapy in atopic dermatitis

Atopic dermatitis is a chronic inflammatory skin disease commonly associated with itching, sleep disturbance and impaired quality of life, and melatonin may have effects on sleep, inflammation and oxidative stress [6]. A randomised controlled trial will evaluate oral melatonin as an adjunct to standard treatment in adults with atopic dermatitis, assigning 130 participants in a 1:1 ratio to standard treatment per the Vietnamese Ministry of Health 2023 guideline or standard treatment plus oral melatonin 6 mg once daily for four weeks [6]. Severity will be assessed using the SCORing Atopic Dermatitis index [6].

Light therapy, cellular energy and oxidative stress in healthy adults and type 1 diabetes

A clinical trial is evaluating the effects of low-level light therapy on cellular energy and oxidative stress in healthy adults and patients with type 1 diabetes [7]. The questions addressed are whether light therapy changes adenosine triphosphate levels and cytochrome c oxidase activity in blood cells, and how the intervention affects oxidative stress markers, specifically glutathione and malondialdehyde concentrations [7]. Blood samples collected before and after light therapy are compared to assess mitochondrial function, and responses of healthy volunteers are compared with those of diabetic participants [7].

Vitamin D in diabetic peripheral neuropathy

Diabetic peripheral neuropathy is among the most common chronic complications of diabetes and a major cause of morbidity, impaired quality of life, sleep disturbance, chronic pain and functional disability [8]. Its pathogenesis is described as multifactorial, involving oxidative stress, chronic inflammation, endothelial dysfunction, mitochondrial injury and microvascular ischemia, leading to progressive nerve damage [8]. Despite symptomatic therapies such as gabapentin, pregabalin and duloxetine, many patients continue to experience persistent neuropathic symptoms, poor sleep quality and impaired daily functioning [8].

Redox mechanisms in cardiac, pulmonary, skeletal muscle and cardiovascular models

Several mechanistic studies inform the broader picture without being the subject of a dedicated section here. Work on cardiac aging reports that ALKBH5-dependent m6A demethylation promotes cardiac aging through SLC38A3 reduction and altered glutamine metabolism [9]. In a pulmonary model, the mitochondrial peptide SHLP2 limited poly(I:C)-induced alveolar epithelial injury by modulating redox, apoptotic, inflammatory and inflammasome responses in type II alveolar epithelial cells [10]. A scoping review examined coffee and coffee-derived bioactive compounds, including caffeine, polyphenols, trigonelline and diterpenes, in relation to skeletal muscle health across mechanistic pathways, preclinical evidence and human outcomes [11]. A further review positions ergothioneine as a diet-derived xenobiotic with OCTN1-mediated disposition and mitochondrial redox regulation, noting that inconsistent results in conventional antioxidant trials are likely attributable to multiple factors including compound selection and dose [12].

If you are reading this for personal health reasons

The materials described on this page are supplied for laboratory research use only, and we do not provide dosing information or medical guidance of any kind. Nothing here is a recommendation to use any compound, and no statement on this page should be read as a promise of any outcome. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Vitamin E Add-On Therapy, Thyroid Function & Oxidative Stress in Levothyroxine-Treated Hypothyroidism — ClinicalTrials.gov
• [2] Effect of Zinc Supplementation on Insulin Resistance and Clinical Features in Women With Polyendocrine Metabolic Ovarian Syndrome — ClinicalTrials.gov
• [3] The NICE-PAD II Trial — ClinicalTrials.gov
• [4] Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome — ClinicalTrials.gov
• [5] GPX4 Expression After Kono-S vs Conventional Anastomosis — ClinicalTrials.gov
• [6] Oral Melatonin as Adjunctive Therapy in Adults With Atopic Dermatitis — ClinicalTrials.gov
• [7] The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic Patients — ClinicalTrials.gov
• [8] Vitamin D in Diabetic Neuropathy — ClinicalTrials.gov
• [9] ALKBH5-Dependent m6A Demethylation Promotes Cardiac Aging Through SLC38A3 Reduction and Glutamine Metabolic Alteration — europe_pmc
• [10] Mitochondrial Peptide SHLP2 Limits Poly(I:C)-Induced Alveolar Epithelial Injury by Modulating Redox, Apoptotic, Inflammatory, and Inflammasome Responses — europe_pmc
• [11] Coffee and coffee-derived bioactive compounds in skeletal muscle health: a scoping review of mechanistic pathways, preclinical evidence and human outcomes — europe_pmc
• [12] Ergothioneine as a diet-derived xenobiotic: OCTN1-mediated disposition, mitochondrial redox regulation, and emerging implications for cardiovascular disease — europe_pmc